Federal officials are extending today’s deadline some people picking a Medicare prescription drug or private health plan because of the crush of last-minute sign-ups.
TUESDAY, Nov. 8 (HealthDay News) — The brains of autistic children have far more neurons in the prefrontal cortex than the brains of kids without autism, finds a new study that could advance research into the disorder.
“For the first time, we have the potential to understand why autism gets started,” said study author Eric Courchesne, a professor of neurosciences at the University of California, San Diego School of Medicine and director of the Autism Center of Excellence.
“Creating brains cells and the correct number of brain cells is absolutely fundamental to building the brain,” said Courchesne. “If there is an excess number of neurons, there must be a negative consequence to that in the way the brain gets wired or organized.”
We’ve been honored by being listed on “The 35 Best Blogs for Epilepsy Support”!
In the past few years, large studies on the epidemiology and genetics of epilepsy and autism have uncovered commonalities between the two disorders. But scientists are only beginning to untangle the biological roots of the overlap.
However, new research suggests that “treatment-resistant epilepsy” is common among patients with autism, and more than one-third of patients in our study group had treatment-resistant epilepsy,” said Dr. Orrin Devinsky, director of the NYU Comprehensive Epilepsy Center, who led the study.
Fed up with generic drugs? Well there are dozens more coming as big-name brands lose their patents…
As it prepares to split into two sectors, Abbott is setting aside “$1.5 billion of litigation reserves” related to ongoing settlement discussions related to Depakote…
Two epilepsy drugs – Lamictal and Keppra – which are currently listed in category C may be dangerous to a fetus and should be listed in category D, according to new data. The difference between the categories is that D shows evidence of risk, but the benefits outweigh the risks…
Where there’s research, there’s hope. So we can only be encouraged to know there are six new epilepsy drugs that have come down the line…
Here’s a brief summary of each…
Watson Laboratories, Inc. has launched the generic version of Keppra XR® following approval of the U.S. Food and Drug Administration (FDA).
Colorectal cancer is the second leading cause of cancer deaths in the U.S. and more than half of over 80 million people over the age of 50 have never been screened.
But now there’s good news for everyone who dreads their mandatory colonoscopy. (Like me.)
It’s a new NONINVASIVE DNA colon cancer screening test that should be available to the general public in 20012!